David Waning

8PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 01, 2024
Preventing loss of sirt1 lowers mitochondrial oxidative stress and preserves C2C12 myotube diameter in an in vitro model of cancer cachexia.

Brian A Hain, Scot R Kimball, David L Waning

|Oct 06, 2022
LP07 and LLC preclinical models of lung cancer induce divergent anabolic deficits and expression of pro-inflammatory effectors of muscle wasting.

Daniel J Belcher, Maria Guitart, Brian Hain

|Sep 10, 2022
Bone-Muscle Crosstalk: Musculoskeletal Complications of Chemotherapy.

Brian A Hain, David L Waning

|Oct 21, 2021
REDD1 deletion attenuates cancer cachexia in mice.

Brian A Hain, Haifang Xu, Ashley M VanCleave

|Oct 19, 2021
Loss of REDD1 prevents chemotherapy-induced muscle atrophy and weakness in mice.

Brian A Hain, Haifang Xu, David L Waning

|Dec 28, 2020
Bone metastases induce metabolic changes and mitophagy in mice.

Jenna Wilcox-Hagerty, Haifang Xu, Brian A Hain

Pageof 2

Frequent Collaborators

1 joint publications

Nabarun Chakraborty

1 joint publications

Melissa A Kacena

1 joint publications

Rasha Hammamieh

1 joint publications

Bradley S Gordon